论文部分内容阅读
目的:观察替米沙坦对冠心病患者血脂的影响。方法:冠心病患者66例,在常规治疗基础上给予替米沙坦80 mg/次,1次/d,口服,疗程6个月;比较治疗前、后血清总胆固醇、高密度脂蛋白、低密度脂蛋白、三酰甘油水平。结果:治疗后高密度脂蛋白较治疗前增高(P<0.05);治疗前、后总胆固醇、三酰甘油和低密度脂蛋白水平比较差异无统计学意义(P>0.05)。结论:替米沙坦可使高密度脂蛋白水平增高。
Objective: To observe the influence of telmisartan on blood lipid in patients with coronary heart disease. Methods: Sixty-six patients with coronary heart disease were treated with telmisartan 80 mg once daily for 6 months on the basis of routine treatment. The levels of serum total cholesterol, high-density lipoprotein, Density lipoprotein, triglyceride levels. Results: After treatment, the levels of HDL were higher than those before treatment (P <0.05). There was no significant difference in total cholesterol, triglyceride and low density lipoprotein between before and after treatment (P> 0.05). Conclusion: Telmisartan can increase the level of high density lipoprotein.